Author

Yajing Fu

First Hospital of China Medical University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

Bryan M. Delfing· 1 shared Christopher LockhartiD· 1 shared Dmitri K. KlimoviD· 1 shared Haibo DingiD· 1 shared Han YangiD· 1 shared Hong ShangiD· 1 shared Hongchi GeiD· 1 shared Jie Lei· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Bryan M. Delfing

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Natural killer cell migration in HIV-infected individuals is inhibited by impairment of HIF-1alpha-mediated glycolysis

Xiaowen Yu, Jie Zhou, Jie Lei, Hongchi Ge, Zining Zhang, Yajing Fu, Xiaoxu Han, Qinghai Hu, Haibo Ding, Wenqing Geng, Hong Shang, Yongjun Jiang

This study identifies that impaired NK cell migration in HIV-infected individuals is due to TIGIT inhibiting HIF-1-mediated glycolysis through PI3K/AKT/mTORC1 or ERK pathways.

Cell Death and Disease · Nov 7, 2025Peer-reviewedImmunology

The decameric repeat (DR) of PSGL-1 functions as a basic antiviral unit in restricting HIV-1 infectivity

Han Yang, Leanna Sealey, Yajing Fu, Bryan M. Delfing, Christopher Lockhart, Linda D. Chilin, Sameer Tiwari, Mohsin Saleet Jafri, Dmitri K. Klimov, Yuntao Wu

This study identifies the decameric repeat (DR) of PSGL-1 as an essential antiviral unit that restricts HIV-1 infectivity by hindering virion attachment to target cells.

bioRxiv · May 14, 2025 · PreprintImmunology